CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC ≥1,000: Results From the CAC Consortium 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study Why NOBLE and EXCEL Are Consistent With Each Other and With Previous Trials Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey Accuracy of Fractional Flow Reserve Derived From Coronary Angiography

Review Article2021 Jan 29;ehaa1097.

JOURNAL:Eur Heart J. Article Link

Patient-tailored antithrombotic therapy following percutaneous coronary intervention

NMR van der Sangen, R Rozemeijer, DRPP CP Yin et al. Keywords: DAPT; patient-tailored antithrombotic therapy; risk stratification

Full Text PDF